Previously criticised for its ineffectual role in the H1N1 pandemic of 2009, Tamiflu is now to be praised for its effects on flu patients thanks to research carried out by the Chinese Centre for Disease Control and Prevention.
The study published in the British Medical Journal showed that out of 1,200 patients who were being treated in a hospital for swine flu, those who were treated with Tamiflu were 80% less likely to develop pneumonia.
Moreover, the research uncovered that beginning the course of Tamiflu (oseltamivir) within 2 days of experiencing flu symptoms, reduced the spell of fever and the patients became less contagious.